Jackson Andrew C., CFO of Calidi Biotherapeutics ($CLDI), made one open market purchase of company shares worth $5,000 in the last 365 days, with the most recent on August 21, 2025. This ranks him 4,577th among 4,983 insiders by purchase amount, below the average of $1.46 million across about 3.3 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 3, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Jackson Andrew C. | Chief Financial Officer | A | Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 28,467,580 | 9999.99% | 0.11% |
| Aug. 21, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Jackson Andrew C. | Chief Financial Officer | P | Common Stock | 2500 | $2.00 | 2,500.0000 | 28,467,580 | 9999.99% | 0.01% |
| Aug. 21, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Jackson Andrew C. | Chief Financial Officer | P | Warrant (right to buy) | 2500 | $0.00 | 2,500.0000 | 28,467,580 | 9999.99% | 0.01% |
| June 17, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Jackson Andrew C. | Chief Financial Officer | A | Stock Options (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |